2m 2m 2m 2m 2m 2m 2m
Harrow (HROW)
NASDAQ
$31.00+$0.39 (+1.29%)
Price as of Oct 02, 2026 4:45 PM EDT- $1.1BMarket Cap
- -35.87%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Harrow (HROW)
$31.00+$0.39 (+1.29%)
HROW | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $30.61 | ||
Change | -$0.19 (-0.62%) | ||
Open | $30.55 | ||
High | $31.10 | ||
Low | $30.27 | ||
Previous Close | $30.80 | ||
Volume | 597,210 | ||
30-Day Average Volume | 564,567 | ||
1-Week Change | -7.52% | ||
1-Month Change | -17.20% | ||
1-Year Change | -35.87% | ||
3-Year Change | 113.01% | ||
5-Year Change | 236.37% | ||
Fundamentals | |||
Shares Outstanding | 37.5M | ||
Total Assets | $416.8M | ||
Market Cap | $1.1B | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $70.6M | ||
Net Income | -$17.3M | ||
Free Cash Flow | -$10.2M | ||
EBIT | -$17.3M | ||
EBITDA | -$16.8M | ||
Net Working Capital | $127.1M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -81 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 75 | ||
P/E | -67 | ||
PEG | -2 | ||
Price/Free Cash Flow | -112 | ||
Price/Operating Cash Flow | -118 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 02/08/2013 | ||
Earnings & Revenue